
BTG International
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
BTG is a global healthcare company focused on Interventional Medicine.
Investor Profile
BTG International has made 8 investments, with 0 in the past 12 months and 50% as lead.
Stage Focus
- Series A (38%)
- Series Unknown (25%)
- Series C (13%)
- Seed (13%)
- Series B (13%)
Country Focus
- United States (38%)
- United Kingdom (38%)
- Sweden (13%)
- China (13%)
Industry Focus
- Medical
- Health Care
- Pharmaceutical
- Biotechnology
- Nanotechnology
- Intelligent Systems
- Developer Platform
- Life Science
- Medical Device
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.